Markers for Ovarian Cancer May Show Up Years Earlier - Advice From Doctor - TCM network 
简体版
繁体版
English
 
Main Page
Diseases Encyclopedia
TCM-News
Advice From Doctor
Diet Therapy
TCM-Health Wellness
Sexual Health
Health Column
Special-featured therapy
Chinese Herbs
TCM-Acupunture
TCM-Tuina
Gufang message
Contact Us
 

China TCM web

Patients should try to come to consult us personally, for those that cannot do that, please send or fax to the professional group your recent symptoms, examination, analysis, early diagnose and case history (including patient's address, telephone number, height, weight), after discussion and diagnosis by the professional group, the treatment plan will be informed to the patient and he/she should receive treatment by postage. One can consult the professional group anytime during the treatment.
 

Contact Us
Tel: +0086 13631453379
Contact:Miss Wang
Email:yizi-ice@hotmail.com
Address:Bei Xi Liu Lu Zhan Dian Zi Bo Shan Dong China
Remittance/Payment:

>>> TCM network - Advice From Doctor  
Doctor Profile
    Dr. Wang Yong, character Shurun,
of Han Nationality, is born to the
Chinese  medicine  aristocratic
family,he has inherited the essence
of traditional Chinese medicine,he
uses ancient secret remedies as the
base and he complies........more
 
Gufang Introduction
    Gufang Chinese medicine
complicated diseases research center
is located at Shan Dong Province Zi
Bo City , ZhangDian Bei Xi Liu Road;
Zi Bo is situated between Lu Zhong
mountain area andLuBei champagne,
located at a unique......more
 
Markers for Ovarian Cancer May Show Up Years Earlier
2010-01-07 【font size: Large Medium Small】  【Close
----------------------------------------------------------------------------------------------------------------------------------------

  Concentrations of several biomarkers begin to grow three years before women are diagnosed with ovarian cancer, but only reach substantial elevation levels over the 12 months before diagnosis, new research finds.

  The findings, published online in the Journal of the National Cancer Institute, expand on previous research into biomarkers known as CA125, HE4, mesothelin, B7-H4, decoy receptor 3 and spondin-2.

  Researchers from Fred Hutchinson Cancer Research Center in Seattle examined blood serum samples from a lung cancer study. They compared samples from 34 women who were diagnosed with ovarian cancer to samples from 70 healthy patients.

  The concentrations of CA125, HE4 and mesothelin increased slightly in the ovarian cancer patients about three years before they were diagnosed with the disease.

  'Serum markers likely will form a key element in any screening regimen, with the lead time and other parameters of each marker or combination of markers being taken into account. The careful evaluation technique applied in the current study fits into a staged approach necessary for testing performance of early markers of disease,' Patricia Hartge, of the U.S. National Cancer Institute, wrote in a commentary accompanying the study.

 


 

guanliyuan
© 2017 TCM network All rights reserved
RecordNumber:(ICP): LuICPBei05008738